SCHEMBL31472797

SCHEMBL31472797

Cn1ccc2cc(-c3c(C#Cc4cscn4)cccc3C(=O)O)ccc21

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CCNC P24863 3/20 0.37
▸ CDK8 P49336 3/20 0.37
▸ HSD11B1 P28845 1/20 0.37
▸ PIK3CD O00329 2/20 0.35
▸ PIK3R1 P27986 2/20 0.35
▸ PIK3CA P42336 1/20 0.35
▸ PIK3CB P42338 1/20 0.35
▸ PIK3CG P48736 1/20 0.35
▸ GRM5 P41594 1/20 0.35
▸ NPC1 O15118 1/20 0.35
▸ RAB9A P51151 1/20 0.35
▸ SMN1; SMN2 Q16637 1/20 0.35
▸ PRKAG1 P54619 1/20 0.34
▸ PRKAA2 P54646 1/20 0.34
▸ PRKAA1 Q13131 1/20 0.34
▸ PRKAB1 Q9Y478 1/20 0.34
▸ MAOB P27338 1/20 0.34
▸ APP P05067 1/20 0.34
▸ GRK5 P34947 1/20 0.33
▸ AR P10275 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16719492 1.00 CCNC (0.37) CCNCCDK8HSD11B1PIK3CDPIK3R1
SCHEMBL16720268 0.83 CCNC (0.36) CCNCCDK8PIK3CDPIK3R1PIK3CA
SCHEMBL16720333 0.81 HSD11B1 (0.43) CCNCCDK8HSD11B1PIK3CDPIK3R1
SCHEMBL16731648 0.81 HSD11B1 (0.39) CCNCCDK8HSD11B1PIK3CDPIK3R1
SCHEMBL16720324 0.79 NPC1 (0.40) GRM5NPC1RAB9ASMN1; SMN2CLK4
SCHEMBL16719723 0.78 HSD11B1 (0.37) CCNCCDK8HSD11B1PIK3CDPIK3R1
SCHEMBL16720114 0.78 DHODH (0.44) GRM5NPC1RAB9ASMN1; SMN2
SCHEMBL16719670 0.78 GPR142 (0.41) PIK3CDPIK3R1PIK3CAPIK3CBPIK3CG
SCHEMBL16719668 0.78 GRM5 (0.43) PIK3CDPIK3R1PIK3CAPIK3CBPIK3CG
SCHEMBL16719945 0.78 KDM4E (0.36) CCNCCDK8PIK3CDPIK3R1PIK3CA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12258314-B2 EBNA1 inhibitors and their method of use THE WISTAR INSTITUTE OF ANATOMY AND BIOLOGY (US) 2025-03-25 — — US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12258314-B2 EBNA1 inhibitors and their method of use EBNA1BP2, MLLT1, PML CCNC 409/4885CDK8 370/4885HSD11B1 2082/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback